Drugs / CRY BC-PLTs
last change Nov 2019 re-read 3 minutes ago

CRY BC-PLTs

Developed for
primary thrombocytopenia · thrombocytopenia
Investigated by
Napolitano Mariasanta · Regione Sicilia

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02032134 Jul 2015 → Jun 2016 primary thrombocytopenia, thrombocytopenia Napolitano Mariasanta Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CRY BC-PLTs “After in vitro validation studies, ad hoc prepared buffy coat-derived pooled platelet concentrates (BC-PLTs), treated with dimethyl sulphoxide (DMSO) and cryopreserved (CRY...” PMID 31753773 ↗ Nov 2019
Route Other “were transfused in patients with severe thrombocytopenia secondary to chemotherapy for acute leukaemia (AL)” PMID 31753773 ↗ Nov 2019